China Investment Roadmap: The Medical Device Industry – New Issue of China Briefing Magazine

Posted by Reading Time: 3 minutes

CB 2014 11_cover_250x350The newest issue of China Briefing Magazine, titled “China Investment Roadmap: The Medical Device Industry,” is out now and available as a complimentary download in the Asia Briefing Bookstore through the month of November.


  • Market Overview: Medical Devices in China
  • Investing in China’s Medical Device Industry
  • Case Study: Choosing a Distribution Model for the Chinese Market

Today’s opportunities for foreign investment in the medical device industry in China are the product of a near perfect storm of factors in the country: social, technological, economic and regulatory.

In the social realm, China’s greying and increasingly wealthy population has created an unprecedented demand for medical products, services and institutions. Here, the capital, technology and expertise of foreign firms hold an indispensable value. Meanwhile, the long-standing pattern of China as a low-tech manufacturer and high-tech importer of medical devices is slowly giving way to more China-side manufacturing of mid-to-high tech devices by foreign-invested enterprises.

Economically, the currently fractured and immature market in low-tech devices will likely see consolidation over the coming years, as trade barriers are lowered and more sophisticated supply chains put in place. And on the regulatory front, China’s new Trademark Law (effective May 1, 2014), in conjunction with alternative dispute resolution (ADR) initiatives such as the Shanghai International Arbitration Centre (“SHIAC”), mean that foreign investors can feel safer than ever bringing their core technologies to China.

In this issue of China Briefing, we present a roadmap for investing in China’s medical device industry, from initial market research, to establishing a manufacturing or trading company in China, to obtaining the licenses needed to make or distribute your products. With our specialized knowledge and experience in the medical industry, Dezan Shira & Associates can help you to newly establish or grow your operations in China and beyond.


Asia Briefing Ltd. is a subsidiary of Dezan Shira & Associates. Dezan Shira is a specialist foreign direct investment practice, providing corporate establishment, business advisory, tax advisory and compliance, accounting, payroll, due diligence and financial review services to multinationals investing in China, Hong Kong, India, Vietnam, Singapore and the rest of ASEAN. For further information, please email or visit

Stay up to date with the latest business and investment trends in Asia by subscribing to our complimentary update service featuring news, commentary and regulatory insight.


Related Reading

Industry Specific Licenses and Certifications in China
In this issue of China Briefing, we provide an overview of the licensing schemes for industrial products; food production, distribution and catering services; and advertising. We also introduce two important types of certification in China: the CCC and the China Energy Label (CEL). This issue will provide you with an understanding of the requirements for selling your products or services in China.


Adapting Your China WFOE to Service China’s Consumers
In this issue of China Briefing Magazine, we look at the challenges posed to manufacturers amidst China’s rising labor costs and stricter environmental regulations. Manufacturing WFOEs in China should adapt by expanding their business scope to include distribution and determine suitable supply chain solutions. In this regard, we will take a look at the opportunities in China’s domestic consumer market and forecast the sectors that are set to boom in the coming years.

Revisiting the Shanghai Free Trade Zone: A Year of Reforms
In this issue of China Briefing, we revisit the Shanghai FTZ and its preferential environment for foreign investment. In the first three articles, we highlight the many changes that have been introduced in the Zone’s first year of operations, including the 2014 Revised Negative List, as well as new measures relating to alternative dispute resolution, cash pooling, and logistics. Lastly, we include a case study of a foreign company successfully utilizing the Shanghai FTZ to access the Outbound Tourism Industry.